Free Trial

Renalytix (RNLX) SEC Filings & 10K Form

$0.45
0.00 (0.00%)
(As of 06/7/2024 ET)

Recent Renalytix SEC Filings

DateFilerForm TypeView
06/05/2024
3:31 PM
Renalytix (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/05/2024
3:17 PM
Jung Joel R (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/28/2024
6:15 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
9:09 AM
Renalytix (Filer)
Form 424B5
05/15/2024
8:23 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
6:20 AM
Renalytix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
6:00 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
11:15 PM
Renalytix (Filer)
Form EFFECT
04/26/2024
6:43 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
4:00 PM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
3:48 PM
Renalytix (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/09/2024
3:51 PM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
3:31 PM
Renalytix (Filer)
Form 424B5
04/08/2024
6:44 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
9:15 AM
CVI Investments, Inc. (Filed by)
Renalytix (Subject)
Form SC 13G
03/29/2024
4:05 PM
Renalytix (Filer)
Form DEF 14A
03/21/2024
2:30 PM
JEFFERSON RIVER CAPITAL LLC (Filed by)
Renalytix (Subject)
Form SC 13D/A
03/14/2024
6:15 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
6:00 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:37 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
5:05 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
6:00 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
6:00 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2024
6:15 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
6:15 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
7:02 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
4:00 PM
Renalytix (Filer)
Form DEFA14A
11/22/2023
3:27 PM
Doran Howard JR (Reporting)
Renalytix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:27 PM
MILLS CHRISTOPHER (Reporting)
Renalytix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:28 PM
Parikh Chirag R. (Reporting)
Renalytix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:28 PM
LEVANGIE DANIEL J (Reporting)
Renalytix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:29 PM
Coste Catherine (Reporting)
Renalytix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
4:15 PM
Renalytix (Filer)
Form DEFR14A
11/13/2023
8:22 AM
Renalytix (Filer)
Form DEF 14A
10/24/2023
7:00 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
7:00 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2023
11:15 PM
Renalytix (Filer)
Form EFFECT
10/09/2023
11:15 PM
Renalytix (Filer)
Form EFFECT
10/09/2023
11:15 PM
Renalytix (Filer)
Form EFFECT
10/05/2023
7:30 PM
Renalytix (Filer)
Form 10-K/A
10/03/2023
6:00 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Breaking - The US Gov. Seized CITGO (Ad)

Do you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).

Get all the details here.
10/02/2023
8:42 PM
Renalytix (Filer)
Form RW WD
10/02/2023
3:00 PM
Renalytix (Filer)
Form RW
09/28/2023
6:31 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
5:49 AM
Renalytix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/28/2023
5:54 AM
Renalytix (Filer)
Form POS AM
09/28/2023
5:55 AM
Renalytix (Filer)
Form POS AM
09/28/2023
5:58 AM
Renalytix (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/28/2023
5:18 AM
Renalytix (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/22/2023
6:00 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2023
3:15 PM
Doran Howard JR (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/21/2023
6:00 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
4:16 PM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2023
3:49 PM
MCLAIN THOMAS H (Reporting)
Renalytix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:24 PM
Renalytix (Issuer)
Sterling O. James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:25 PM
Fleming Fergus (Reporting)
Renalytix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:26 PM
MCLAIN THOMAS H (Reporting)
Renalytix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:27 PM
McCullough James Renwick (Reporting)
Renalytix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:28 PM
Coste Catherine (Reporting)
Renalytix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:29 PM
Donovan Michael J. (Reporting)
Renalytix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:20 PM
LEVANGIE DANIEL J (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:21 PM
Lium Erik (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:21 PM
McCullough James Renwick (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:22 PM
MCLAIN THOMAS H (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:23 PM
MILLS CHRISTOPHER (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:23 PM
Parikh Chirag R. (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:24 PM
Renalytix (Issuer)
Scannell Timothy J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:24 PM
Renalytix (Issuer)
Sterling O. James (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:19 PM
Coste Catherine (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:19 PM
Donovan Michael J. (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:20 PM
Fleming Fergus (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
1:30 PM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
7:55 AM
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
MOUNT SINAI HEALTH SYSTEM, INC. (Reporting)
MOUNT SINAI HOSPITAL (Reporting)
MOUNT SINAI HOSPITALS GROUP, INC. (Reporting)
Renalytix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
7:00 AM
Renalytix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
6:00 AM
Renalytix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2023
6:01 AM
Renalytix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:RNLX) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners